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Abstract
Background: Saliva samples are easily collectable and non-invasive, and the monitoring of natural steroidal
hormones, such as estrone (E1), 17b-estradiol (E2), estriol (E3), progesterone (P), and testosterone (T), in saliva has
attracted much attention due to its numerous potential clinical and health-related applications. Because E1, E2, E3,
P and T are useful indicators in numerous clinical and health-related diagnoses, there is a need for simultaneous
determination.
Results: A gas chromatography-mass spectrometric assay was developed for rapid simultaneous determination of
E1, E2, E3, P and T in saliva for clinical diagnoses. Extraction was achieved with a liquid extraction using 3.0 mL of
pentane. The extract was dried and silylated with N-methyl-N-(trimethylsilyl) trifluoroacetamide/NH4I (100:2) under a
catalysis of 1.5% dithioerythritol for 10 min at 90°C. The accuracy of the analytes was in the range of 96% to 112%
at concentrations of 0.05 and 0.10 μg/L (5.0 and 10.0 μg/L for E3), respectively, with relative standard deviations of
less than 11%. The lowest quantification limits were from 0.002 to 0.6 μg/L for 1.0 mL of saliva.
Conclusion: Natural steroidal hormones were detected in the concentration ranges of nd to 0.2 μg/L in human
saliva. The salivary testosterone values in the patients with prostatic carcinoma were significantly lower than in
normal males. The method may useful in numerous clinical and health-related diagnoses.
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Background
Saliva samples are easily collectable, non-invasive, and
pose no risk to the health of the subjects. Salivary con-
centrations of steroids generally reflect serum concen-
trations of free active steroids; a significant correlation
between salivary and serum steroid concentrations was
shown in men [1-4]. Therefore, saliva has been used in
a number of human and nonhuman studies to deter-
mine the presence of a wide range of substances, includ-
ing biological substances and pharmaceutical drugs [5].
The monitoring of natural steroidal hormones, such as
estrone (E1), 17b-estradiol (E2), estriol (E3), progester-
one (P), and testosterone (T), in saliva has attracted
much attention due to its numerous potential clinical
and health-related applications [1-4,6-14].
Clinical monitoring of E2 is desirable for the study
and treatment of hormone-dependent carcinomas [5],
and investigating ovarian function [6]. The measurement
of salivary E3 concentrations could be useful in evaluat-
ing antidepressant use during pregnancy [7] and the
simultaneous measurement of salivary E3 and P concen-
trations could be useful in the prediction of preterm
birth [8]. Measurement of salivary E1 and salivary T
could give useful information in evaluating of pregnant
sows [9], and the androgenic function of patients with
prostatic carcinoma after medical or surgical orchiect-
omy [10] and late-onset hypogonadism [11,12], respec-
tively. Monitoring T in children’s saliva affords a unique
view of the effects of behavioral factors on development
[15].
Many analytical procedures have been proposed to
determine trace level for natural steroidal compounds in
saliva, most of which are based on determining E1 [9],
E2 [16], E3 [17,18], P [18], and T [19] levels in saliva
using enzyme immunoassay. Although this technique
will continue to be the method of choice for routine use
in clinical fields, especially in large population-based
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quantification capability.
Recently, liquid chromatography-tandem mass spec-
trometric (LC-MS/MS) methods has been developed
and validated for the quantification of salivary T
[4,12,20,21]. These methods are restrictive for the quan-
tification of salivary T, and require complicated clean-
up procedures and expensive instruments.
Several researchers have analyzed the salivary T in
human saliva using a gas chromatography-mass spectro-
metry after the t-butyldimethylsilyl ether and methyl
oxime, t-butyldimethylsilyl ether derivatization [22,23].
These methods are also restrictive for the quantification
of salivary T, and require immunoadsorption as sample
treatment. Silylation is a versatile method used to deri-
vatize the organic compounds that contain the hydroxyl
group to enhance the GC-MS properties. Reduction of
reaction time may be more effective in determining the
natural steroids in saliva.
T h ep u r p o s eo ft h ep r e s e n ts t u d yi st od e v e l o pas e n -
sitive and simultaneous determination method for nat-
ural steroidal hormones (E1, E2, E3, P and T) in saliva
and to evaluate the increased risk of various disorders.
Experimental
Chemicals and reagents
The following chemicals were purchased from Sigma
(St. Louis, MO, USA): estrone, 17b-estradiol, estriol,
progesterone, testosterone, testosterone-d3, dithioery-
thritol, NH4I and N-methyl-N-(trimethylsilyl) trifluoroa-
cetamide (MSTFA). For the reagent, analytical grade
sodium sulfate (Sigma, St. Louis, MO, USA) was used.
Acetonitrile and pentane (E. Merck, Darmstadt, Ger-
many) were used for the solvents.
Collection and extraction procedure of saliva
The study was approved by the institutional review
board at the Kongju national university, and written
informed consent was obtained from each subject. Saliva
(ca. 1.2 mL) was directly collected into a collecting tube
(without a collection device) from 10 volunteers who
did not take hormone supplements or drugs that influ-
ence steroid hormone biosynthesis and metabolism. The
volunteers did not smoke, eat and drink or brush their
teeth within 1 h prior to the sample collection. Saliva
(ca. 1.2 mL) was also taken from five patients with pro-
static carcinoma under the treatment in a University
Hospital (Dejoen, Korea). The sample collection time
was between ten and eleven o’clock in the morning. It
was stored in a glass collection tube below -20°C until
use. After thawing, a 1.0 mL sample was placed in a 10
mL test tube and 25.0 μL of a testosterone-d3 internal
standard solution (10.0 μg/L in acetonitrile) was added
to the solution. The solution was extracted with 3.0 mL
of pentane by subjecting the mixture to vortex mixing
for 1 min after adding 3.0 g of dried sodium sulfate.
The organic phase was dried in nitrogen stream.
Derivatization
The dry residue was dissolved with 50 μL of silylating
reagents (MSTFA + 2.0% NH4I + 1.5% dithioerythritol,
v/w/w) and the tubes were heated for 10 min at 90°C,
and a 2 μL sample of the solution was injected into the
GC system.
Gas chromatography-mass spectrometry
All mass spectra were obtained with an Agilent 6890/
5975 instrument. The ion source was operated in the
electron ionization mode (EI; 70 eV, 230°C). Full-scan
mass spectra (m/z 40-800) were recorded for the analyte
identification. Separation was achieved with a HP fused-
silica capillary column with a cross-linked 5% phenyl
methylsilicone (DB 5); the column has a length of
approximately 30 m, an inner diameter of 0.25 mm and
a film thickness of 0.25 μm. Samples were injected in a
splitless mode. The flow rate of the helium was 1.0 mL/
min.
The operating parameters were as follows: injector
temperature, 310°C; transfer line temperature, 300°C;
and oven temperature, programmed from 150°C at 12°
C/min to 310°C (hold for 4 min). The ions that were
selected for monitoring by the SIM were m/z 414, 399
and 309 for E1, m/z 416, 326 and 285 for E2, m/z 504,
345 and 311 for E3, m/z 458, 443 and 157 for P, m/z
432, 417, and 208 for T, and m/z 435, 420, and 209 for
T-d3 (internal standard).
Calibration and quantification
The calibration curves for the E1, E2, E3, P and T were
established through extraction and derivatization after
the addition of 0.002, 0.010, 0.025, 0.050 and 0.10 ng/
mL of the standards and 0.25 ng/mL of the internal
standard into 1.0 mL of saliva. Saliva (ca.1 . 2m L )f o r
the calibration curve was collected from healthy volun-
teer, who did not smoke, eat and drink or brush their
teeth within 1 h prior to the sample collection. The
ratio of the standard peak area to that of the internal
standard was used in the quantification of the com-
pound. The quantification ion was m/z 414 for E1, m/z
416 for E2, m/z 504 for E3, m/z 458 for P, m/z 432 for
T, and m/z 435 for T-d3 (internal standard)
Results and discussion
Derivatization
E1, E2, E3, P and T contain more than one derivatizable
functional group. E1 has a hydroxyl group in the aro-
matic ring and an enolic carbonyl group, and E2 and E3
contain a hydroxyl group of the aromatic ring and one
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tively. P contains two carbonyl groups and T contains a
carbonyl group and a hydroxyl group of the aliphatic
ring (Table 1).
To develop a rapid derivatization method of steroids
with multi-functional groups, the first attempt located
the condition in order to silylate only at the hydroxyl
group of the steroid under mild condition using
MSTFA. However, it was unsuccessful because the deri-
vatization was not quantitative. Furthermore, an attempt
to develop a rapid derivatization method for all func-
tional groups of steroids by changing the amount of cat-
alyzing agents, the reaction temperature, and reaction
time was also undertaken. The MSTFA as a silylating
reagent and NH4-I/dithioerythritol as catalyzing agents
were tested in terms of the reactivity of the derivatives.
The derivatization was performed for various NH4-I and
dithioerythritol concentrations (0.3, 1.0, 1.5, 2.0, 3.0, 4.0
and 5.0 wt % to MSTFA weight). The rapid derivatiza-
tion was reached with 2.0% of NH4-I and 1.5% of
dithioerythritol and the yield remained beyond the cata-
lyzing agent amount.
The derivatives were analyzed at reaction times of 10,
20, 30, 40 and 60 min at 85, 90 and 95°C. When the
reaction temperature and time increased to 90°C and 10
min, the derivatization yield achieved its maximum.
As a result, the steroids showed a rapid and complete
reaction in 10 min at 90°C with MSTFA/NH4-I (100:2)
containing 1.5% dithioerythritol. A ketone group of E1
and T, and two ketone groups of P were completely
converted to TMS-enol in 10 min in these conditions.
Method validation
Figure 1 and 2 show chromatograms of the bis-TMS-E1,
bis-TMS-E2, tri-TMS-E3, bis-TMS-P, bis-TMS-T and
bis-TMS-T-d3 in the standard solution and a real sam-
ple. The peaks are symmetrical and no tailing can be
seen. There are no extraneous peaks observed in the
chromatogram of the sample at the analyte retention
times. The retention times of bis-TMS-E1, bis-TMS-E2,
bis-TMS-T-d3, bis-TMS-T, tri-TMS-E3 and bis-TMS-P
were 11.29, 11.42, 11.44, 11.45, 12.70 and 12.79 min,
respectively.
The mass fragmentation of the analytes under electron
ionization at 70 eV is summarized in Table 2. The
molecular ion and the fragment ions formed by the loss
o fam e t h y lg r o u p ,H O T M S ,O T M S+C H 4 and TMS-
O-CH2-CH3 from the molecular ion were characteristic.
Liquid-liquid extraction (LLE) with pentane was selected
for the rapid extraction of steroids in saliva and the use of
dried sodium sulfate in the sample allow the most water
to remove from the sample, to increase the recovery of
Table 1 Molecular formula and mass of target compounds and their derivatives
Steroids Corresponding Derivative Products
Full
Name
Short
Name
Chemspider
ID
Molecular
Formula
Molecular Weight Structure Short
Name
Molecular
Formula
Molecular Weight
Estrone E1 5660 C18H22O2 270.4 bis-TMS-E1 C24H38O2Si2 414.3
17b-Estradiol E2 5554 C18H24O2 272.4 bis-TMS-E2 C24H40O2Si2 416.4
Progesterone P 5773 C21H30O2 314.5 bis-TMS-P C27H46O2Si2 458.3
Testosterone T 5791 C19H28O2 288.4 bis-TMS-T C25H44O2Si2 432.3
Estriol E3 5553 C18H24O3 288.4 tri-TMS-E3 C27H48O3Si3 504.4
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without centrifugation. The total sample treatment time
including derivatization was reduced to 20 min.
Five saliva samples spiked at a concentration of 0.05
and 0.10 μg/L were prepared and the relative recovery
was calculated in terms of the percentage of derivatives
E1
E2
E3
P
T
T-d3 
Figure 1 GC-MS chromatogram after the extraction and derivatization of saliva spiked in concentration of 0.10 μg/L (that of estriol =
2.0 μg/L).
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were between 93% and 111% as described in Table 3.
A linear relation with an average correlation coeffi-
cient of 0.999 was found in the examination of a typical
standard curve. A least squares fit was used to compute
the regression line of the peak area ratios of the bis-
TMS-E1, bis-TMS-E2, tri-TMS-E3, bis-TMS-P and bis-
TMS-T to bis-TMS-T-d3 on concentrations. Table 3
Blank
m/z=416 
m/z=432 
m/z=458 
Real sample 
m/z=416 
m/z=432 
m/z=458 
Figure 2 GC-MS chromatogram after the extraction and derivatization of blank and real saliva sample. The concentrations of estradiol
(m/z 414), progesterone (m/z 458) and testosterone (m/z 432) were 0.008 μg/L, 0.013 μg/L and 0.035 μg/L, respectively.
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cients for the steroids.
Table 3 confirms that the reproducibility of the assay
was very good. For the five independent determinations
at 0.05 and 0.10 μg/L, the coefficient of variation was
less than 11%.
The limit of detection (LOD) and the limit of quantifi-
cation (LOQ) were defined as the analyte concentration
corresponding to a signal/noise ratio of 3 and 10 from
samples (n = 7) spiked at the concentration of 0.01 μg/L
in saliva. LOQs were 0.003 μg/L for E1, P and T, 0.002
μg/L for E2 and 0.3 μg/L for E3 using a 1.0 mL of saliva.
Table 4 compares various analytical methods for deter-
mining 5 steroids in saliva. The method permits the
determination of 5 steroids well below or similar those
reported previously [8,9,11,13,16,19].
Real sample analysis
The target compounds in 10 healthy volunteer and 5
patient saliva samples were analyzed. Confirmation of
trace analytes was achieved by use of three characteristic
MS ions. The characteristic ion ratios and GC retention
times were matched with those of standard compounds.
Analytical results of natural steroidal hormones in sal-
iva were shown in Table 5. In this study, the female
subjects had E2 and P salivary concentrations of 0.008
to 0.016 μg/L and 0.009 to 0.028 μg/L, respectively,
while these were not detected in the saliva of the male
subjects. Generally, E2 and P levels are used to assess
fertility, ovarian function and long term health (reduc-
tion in heart disease and osteoporosis) in the concentra-
tion range of 0.002 to 0.05 μg/L [6,8]. The proposed
method had enough sensitivity to be beneficial in evalu-
ating the disorders.
The salivary T concentrations of healthy volunteers
were in a range of 0.032 to 0.040 μg/L in the female
subjects, and in a range of 0.077 to 0.200 μg/L in the
male subjects in this study. Otherwise, testosterone con-
centrations in saliva 5 patients with prostatic carcinoma
were measured in a range of not detected to 0.027 μg/L.
The salivary testosterone values in these patients were
significantly lower than in normal males. The proposed
method also has sufficient sensitivity for the estimate of
the androgenic function of patients with prostatic
carcinoma.
E1 and E3 were not detected in any saliva samples in
this study. The normal concentration range fell below
the detectability levels of this method. Heine et al.
reported that an E3 measurement of 2.1 μg/L predicted
an increased risk of preterm labor and delivery [24]. Ele-
vated levels of estriol (0.9-2.1 μg/L) are an indication of
preterm births [8] and show higher than LOQ (0.3 μg/
L) of E3 using the proposed method. The results suggest
that the measurement of salivary E3 concentration using
the proposed method can evaluate the increased risk of
preterm labor and delivery.
Table 2 Mass fragmentation of steroid derivatives
Derivative M
+ M
+-C H 3 M
+- HOTMS M
+- OTMS-CH4 M
+-TMSO-CH2-CH3 D-ring cleavage Others
di-TMS-E1 414(87.2)* **399(55.1) - **309(16.6) - 285(4.8) 231(4.3)
di-TMS-a-E2 416(94.1)* 401(7.1) **326(10.6) 309(3.5) 298(9.4) **285(72.4) 129(32.4)
tri-TMS-E3 504(76.9)* 489(9.3) 414(7.7) 399(5.0) 386(26.4) 285(23.7) **345(39.6), **311(36.8)
di-TMS-P 458(63.5)* **443(46.5) - 353(4.1) - - **157(32.9)
di-TMS-T 432(100)* **417(13.1) 342(1.3) 327(2.0) - - **208(11.1)
di-TMS-T-d3 435(100)* **420(16.9) 345(1.5) 330(2.4) - - **209(17.5)
* = the quantification ion; ** = the qualification ion; () = relative abundance
Table 3 Method validation results of the target compounds
Compound Retention Time
(min)
Calibration curve Precision and Accuracy (n = 5) Recovery (%)
(n = 5)
Linear Equation R
2 Spiked Conc (μgL
-1) Accuracy (%) Precision (%)
bis-TMS-E1 11.29 y = 0.0707x - 0.0001 0.9982 0.05 100 7.18 104 ± 7.4
0.10 112 5.62 105 ± 5.9
bis-TMS-E2 11.42 y = 0.0768x + 0.0003 0.9979 0.05 104 10.8 93.0 ± 10.0
0.10 101 4.74 106 ± 5.0
tri-TMS-E3 12.70 y = 0.3431x + 0.0002 0.9986 5.0 112 8.75 111 ± 8.7
10.0 104 8.86 94.4 ± 7.9
TMS-P 12.79 y = 0.0315x + 0.0003 0.9986 0.05 108 6.08 98.6 ± 6.0
0.10 96.0 3.12 105 ± 3.3
bis-TMS-T 11.45 y = 0.1738x + 0.0037 0.9986 0.05 108 6.76 101 ± 4.2
0.10 97.0 6.00 108 ± 4.8
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ing of E1, E2, E3, P, and T using the proposed method
can evaluate the increased risk of many hormone depen-
dant disorders.
Conclusions
A sensitive and simultaneous method has been devel-
oped to analyze natural steroids in human saliva. The
silylation derivatives of steroids containing multifunc-
tional groups with MSTFA/NH4I (100:2) containing
dithioerythritol for 10 min at 90°C have good chromato-
graphic properties and offer a single derivative product.
The extraction of these compounds from saliva with
pentane and dried sodium sulfate yields a high rate of
recovery with a small degree of variation. Furthermore,
the quantification of the steroids is excellent. The linear
calibration curves cover a range of LOQ to 100 μg/L,
and the LOQs are 0.002 to 0.3 μg/L for a 1.0 mL sample
of saliva. The natural steroids present in saliva were
determined. In the present study, the suggested method
enables the successful determination of trace amounts
of natural steroidal compounds in saliva. The results
suggest that the measurement of salivary E1, E2, E3, P,
and T concentrations using the proposed method can
evaluate the increased risk of various disorders.
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